Cargando…

Urinary CXCL1: A Novel Predictor of IgA Nephropathy Progression

BACKGROUND: IgA nephropathy (IgAN) is the most common form of primary glomerulonephritis worldwide. In recent years, consistent efforts have been made to develop new non-invasive biomarkers for IgAN progression. In our previous in vitro study we found mesangial derived CXCL1 as a contributor for kid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yanfeng, Zhu, Li, Zhou, Tong, Zhang, Qingxian, Shi, Sufang, Liu, Lijun, Lv, Jicheng, Zhang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376727/ https://www.ncbi.nlm.nih.gov/pubmed/25816025 http://dx.doi.org/10.1371/journal.pone.0119033

Ejemplares similares

Synergistic Effect of Mesangial Cell-Induced CXCL1 and TGF-β1 in Promoting Podocyte Loss in IgA Nephropathy
por: Zhu, Li, et al.
Publicado: (2013)

Zonulin, as a marker of intestinal permeability, is elevated in IgA nephropathy and IgA vasculitis with nephritis
por: Li, Qianqian, et al.
Publicado: (2022)

Clinical and pathological characteristics in elderly patients with IgA nephropathy
por: Zhang, Yongji, et al.
Publicado: (2023)

Increased plasma sVCAM-1 is associated with severity in IgA nephropathy
por: Zhu, Li, et al.
Publicado: (2013)

The Role of Complement in Microangiopathic Lesions of IgA Nephropathy
por: Li, Jingyi, et al.
Publicado: (2022)

Plasma Soluble Urokinase Receptor Level Is Correlated with Podocytes Damage in Patients with IgA Nephropathy
por: Zhao, Yanfeng, et al.
Publicado: (2015)

Effect of SGLT2 inhibitors on the proteinuria reduction in patients with IgA nephropathy
por: Dong, Yaping, et al.
Publicado: (2023)

Severe Adverse Effects Associated With Corticosteroid Treatment in Patients With IgA Nephropathy
por: Cai, Qingqing, et al.
Publicado: (2017)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

The predictive value and response to immunosuppressive therapy of IgA nephropathy patients with crescents in a large retrospective Chinese cohort
por: Guo, Yingman, et al.
Publicado: (2023)

Urinary Uromodulin Excretion Predicts Progression of Chronic Kidney Disease Resulting from IgA Nephropathy
por: Zhou, Jingjing, et al.
Publicado: (2013)

The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression
por: Zhao, Na, et al.
Publicado: (2012)

Implication of Urinary Complement Factor H in the Progression of Immunoglobulin A Nephropathy
por: Liu, Maojing, et al.
Publicado: (2015)

Noninvasive Urinary Monitoring of Progression in IgA Nephropathy
por: Yang, Joshua Y. C., et al.
Publicado: (2019)

Glomerular C4d Deposition and Kidney Disease Progression in IgA Nephropathy: A Systematic Review and Meta-analysis
por: Jiang, Yuanyuan, et al.
Publicado: (2021)

Elevated Urinary IL-6 Predicts the Progression of IgA Nephropathy
por: Zhao, Wenjun, et al.
Publicado: (2022)

A validation study of crescents in predicting ESRD in patients with IgA nephropathy
por: Zhang, Xiaoyan, et al.
Publicado: (2018)

Safety Evaluation of COVID-19 Vaccine in Patients With IgA Nephropathy or IgA Vasculitis Nephritis
por: Zan, Jincan, et al.
Publicado: (2022)

Complement Activation Is Associated With Crescents in IgA Nephropathy
por: Wang, Zi, et al.
Publicado: (2021)

Case Report: A Pathogenic Missense Variant of WT1 Cosegregates With Proteinuria in a Six-Generation Chinese Family With IgA Nephropathy
por: Li, Qianqian, et al.
Publicado: (2022)

Propensity of IgA to self-aggregate via tailpiece cysteine-471 and treatment of IgA nephropathy using cysteamine
por: Xie, Xinfang, et al.
Publicado: (2021)

Immune Characteristics of IgA Nephropathy With Minimal Change Disease
por: Li, Huixian, et al.
Publicado: (2021)

Urinary peptidome analysis in CKD and IgA nephropathy
por: Li, Zewen, et al.
Publicado: (2023)

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
por: Fukao, Yusuke, et al.
Publicado: (2022)

Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management
por: Selvaskandan, Haresh, et al.
Publicado: (2020)

Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy
por: Chen, Pei, et al.
Publicado: (2018)

Increased APRIL Expression Induces IgA1 Aberrant Glycosylation in IgA Nephropathy
por: Zhai, Ya-Ling, et al.
Publicado: (2016)

Predictors of long term outcomes of IgA nephropathy
por: Kabir, U, et al.
Publicado: (2012)

Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
por: Suzuki, Hitoshi, et al.
Publicado: (2016)

Role of telitacicept in the treatment of IgA nephropathy
por: Wu, Lijun, et al.
Publicado: (2023)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Urinary miRNA profile for the diagnosis of IgA nephropathy
por: Szeto, Cheuk-Chun, et al.
Publicado: (2019)

Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome?
por: He, Jia-Wei, et al.
Publicado: (2022)

Platelet-to-Albumin Ratio: A Novel IgA Nephropathy Prognosis Predictor
por: Tan, Jiaxing, et al.
Publicado: (2022)

Visit-to-visit variability in blood pressure and kidney disease progression in IgA nephropathy
por: Tang, Chen, et al.
Publicado: (2022)

Uncoupling of Glomerular IgA Deposition and Disease Progression in Alymphoplasia Mice with IgA Nephropathy
por: Aizawa, Masashi, et al.
Publicado: (2014)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Urinary complement proteins in IgA nephropathy progression from a relative quantitative proteomic analysis
por: Niu, Xia, et al.
Publicado: (2023)

Role of abnormal glycosylated IgA1 and interstitial transformation of glomerular endothelial cells in the development and progression of IgA nephropathy
por: Jia, Wanyu, et al.
Publicado: (2023)

Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pifu45h7guo4spllltrh30jl42